WO2006075716A1 - Instrument d'administration de medicament et son procede de fabrication - Google Patents

Instrument d'administration de medicament et son procede de fabrication Download PDF

Info

Publication number
WO2006075716A1
WO2006075716A1 PCT/JP2006/300398 JP2006300398W WO2006075716A1 WO 2006075716 A1 WO2006075716 A1 WO 2006075716A1 JP 2006300398 W JP2006300398 W JP 2006300398W WO 2006075716 A1 WO2006075716 A1 WO 2006075716A1
Authority
WO
WIPO (PCT)
Prior art keywords
angle
shape
convex portion
base
drug delivery
Prior art date
Application number
PCT/JP2006/300398
Other languages
English (en)
Japanese (ja)
Inventor
Koji Omichi
Kensuke Shima
Munehisa Fujimaki
Seiji Tokumoto
Hirotoshi Adachi
Original Assignee
Fujikura Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujikura Ltd., Hisamitsu Pharmaceutical Co., Inc. filed Critical Fujikura Ltd.
Priority to JP2006552996A priority Critical patent/JP5053645B2/ja
Publication of WO2006075716A1 publication Critical patent/WO2006075716A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150274—Manufacture or production processes or steps for blood sampling devices
    • A61B5/150282—Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150977—Arrays of piercing elements for simultaneous piercing
    • A61B5/150984—Microneedles or microblades
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053—Methods for producing microneedles

Definitions

  • the present invention relates to a drug delivery device for use in a drug delivery system such as administration of a drug to a living body or aspiration extraction of blood from a living body, and is particularly painless and can be inserted under the skin.
  • the present invention relates to a device for transporting a pharmaceutical product capable of providing a wide range of effective pharmaceutical products.
  • DDS Drug delivery systems
  • TTS transdermal therapeutic system
  • a technique which is generically called a transdermal therapeutic system (TTS)
  • TTS transdermal therapeutic system
  • pharmaceuticals that can be applied to TTS have been limited to those with high skin permeability, such as -troglycerin, isosorbide nitrate, and clozine.
  • drug delivery devices have been proposed.
  • Non-Patent Document 1 describes that the surface of Si, which is the base, is dry-etched with a mixed gas of SF and O. Disclosed is a device for transporting a pharmaceutical product obtained by forming an array of needles having a height of about 100 m (which is described as “micro mouth-one dollar” in Non-Patent Document 1). ing.
  • This Non-Patent Document 1 discloses puncturing the skin using this array of needle-like bodies, transporting a pharmaceutical product from the needle-like body and transporting it to the human body (see Non-Patent Document 1).
  • Patent Documents 1 to 3 disclose a technique for forming an array of needle-like bodies (in Patent Document 1, described as microneedles V). Furthermore, in Patent Document 1, a through-hole passage penetrating from the back surface of the base portion to the surface is formed at the center of the needle-shaped body to form a hollow needle-shaped body (described as a hollow microneedle in Patent Document 1). Is disclosed.
  • Non-Patent Document 1 DV McAllister et al, "MICRO FABRICATED MICRONEEDLES: AN OVEL APPROACH TO TRANSDERMALDRUG DELIVERY", Proceed. Int'l. Symp. Control. Rel. Bioact. Mater., 25 ( 1998) Controlled Release Society. Inc.
  • Patent Document 1 Pamphlet of International Publication No. 99Z64580
  • Patent Document 2 Pamphlet of International Publication No. 00Z05166
  • Patent Document 3 Patent No. 3696513
  • Non-Patent Document 1 the structure of the arrayed needle-like body disclosed in Non-Patent Document 1 that actually transports a pharmaceutical product has been clarified.
  • the hollow needle-like bodies disclosed in Patent Documents 1 to 3 disclose means for transporting pharmaceuticals and blood through the through-holes, but the present technology has a small opening diameter (in the examples) The diameter is limited to 15 m). Since ordinary medicines and blood have a very high viscosity, there is a problem that they do not flow in a through-hole having such a small opening diameter. Increasing the opening diameter (for example, 50 m in diameter) can be easily performed with this technology, but in this technology, it means that the tip diameter of the needle-like body also increases, making it impossible to puncture the skin. End up. In these conventional technologies, there are two further problems in reducing the needle tip diameter. That is, the mechanical strength of the needle-like body is weak because the thickness of the needle-like portion is limited, and the allowable range of the position accuracy of the through hole is reduced due to the limitation of the thickness, and the yield is reduced. Mari is a very bad point.
  • the present invention has been made in view of the above circumstances, and "controlled release of a pharmaceutical product" in which a pharmaceutical product is regulated and released at a constant rate over a certain period of time, and the pharmaceutical product is selectively transported to the affected area.
  • the purpose of the present invention is to provide a drug delivery device that can perform drug administration or blood suction extraction efficiently, while being able to be ⁇ targeted for pharmaceutical products '' and being able to be inserted under the skin without pain. To do.
  • the present invention provides a substantially columnar shape, a substantially cylindrical shape, a base portion, a first angle with respect to the surface thereof, and a second angle different from the first angle.
  • a device for transporting a pharmaceutical product characterized by having a convex portion having a shape selected from the group consisting of a frustum shape and a substantially frustum shape.
  • the present invention includes a base and a convex portion having a shape selected from the group consisting of a substantially columnar shape, a substantially frustum shape, and a substantially frustum shape standing at a first angle with respect to the surface thereof. And a convex portion having an inclined surface having a second angle different from the first angle.
  • the second angle is preferably smaller than the first angle.
  • the first angle is preferably 70 degrees to 90 degrees, and the second angle is preferably 50 degrees to 80 degrees.
  • a through-hole that penetrates from the back of the base to the tip of the convex is formed.
  • the opening area of the through hole is preferably 2 ⁇ 10_3 mm 2 or more.
  • the convex part and the base part are made of a silicon material! /.
  • the present invention includes a step of forming a convex portion having a shape selected from the group consisting of a substantially columnar shape, a substantially frustum shape, and a substantially frustum-like shape standing at a first angle with respect to the surface of the base portion. And a step of forming an inclined surface having a second angle different from the first angle on the convex portion. [0011] Further, the present invention provides a step of forming an opening serving as a through hole path penetrating from the rear surface of the base portion to the tip of the convex portion, and standing on the surface of the substrate at a first angle with respect to the surface.
  • a method for producing a drug delivery device is provided.
  • the step of forming the inclined surface having the second angle is preferably performed by selectively irradiating the base material surface with ionized gas.
  • the convex portion and the base portion are preferably made of a polylactic acid material among the thermoplastic polymers which may be made of a thermoplastic polymer.
  • a mold having pores for forming a convex portion and a base material are disposed to face each other, and at least one of the mold and the base material is heated and then applied to the base material.
  • a method for producing a pharmaceutical product transporting device characterized by comprising a step of applying pressure to transfer the shape of a mold to a substrate and a step of cooling to release the substrate.
  • the drug delivery device of the present invention is a substantially columnar, substantially frustum that is erected with a base, a first angle with respect to the surface thereof, and a second angle different from the first angle. And a convex portion having a shape selected from the group consisting of substantially conical shapes, the tip of the convex portion can be sharply formed, and the puncture property to the skin can be improved.
  • a through-hole having a large opening diameter can be formed on the convex portion having a shape selected from the group consisting of a substantially columnar shape, a substantially frustum shape, and a substantially frustum shape without impairing the puncture property to the skin.
  • a shape selected from the group consisting of a substantially columnar shape, a substantially frustum shape, and a substantially frustum shape without impairing the puncture property to the skin.
  • the types of pharmaceutical products that can be applied also increase.
  • the puncture property can be maintained regardless of the thickness of the convex portion formed at this time.
  • the convex portion having a shape selected from the group consisting of a substantially columnar shape, a substantially frustum shape, and a substantially conical shape is formed with an inclined surface having a second angle, the thickness of the bottom bottom portion of the convex portion Increases the mechanical strength.
  • FIG. 1A is a plan view of an array of painless needles according to a first embodiment of the present invention.
  • FIG. 1B is a cross-sectional view taken along the line A-B in FIG. 1A.
  • 1C is an enlarged perspective view of the convex portion of FIG. 1A.
  • FIG. 2 is a diagram showing each part a to e and angles 0 1, 0 2 of the array of painless needles of the first embodiment.
  • FIG. 3 is a cross-sectional view sequentially illustrating manufacturing steps of the array of painless needles of the first embodiment.
  • FIG. 4 is a configuration diagram showing an example of a dry etching apparatus used in step C in FIG. 3.
  • FIG. 5A is a plan view of an array of painless needles according to a second embodiment of the present invention.
  • FIG. 5B is a cross-sectional view taken along the line A-B in FIG. 5A.
  • FIG. 5C is an enlarged perspective view of the convex portion of FIG. 5A.
  • FIG. 6 is a diagram showing each part f ⁇ ; j and angles 0 1, 0 2 of the arrayed painless needle of the second embodiment.
  • FIG. 7 is a cross-sectional view sequentially showing manufacturing steps of the array of painless needles of the second embodiment.
  • FIG. 8 is a configuration diagram showing an example of a focused ion beam etching apparatus used in FIG. 7.
  • FIG. 9A is a plan view of an array of painless needles according to a third embodiment of the present invention.
  • FIG. 9B is a cross-sectional view taken along the line A-B in FIG. 9A.
  • FIG. 9C is an enlarged perspective view of the convex portion of FIG. 9A.
  • FIG. 10 is a diagram showing each part k to p and angles 0 1 and 0 2 of the arrayed painless needle of the third embodiment.
  • FIG. 11 is a cross-sectional view sequentially showing manufacturing steps of the array of painless needles of the third embodiment.
  • FIG. 12A is a cross-sectional view sequentially illustrating manufacturing steps of the array of painless needles of the fourth embodiment.
  • FIG. 12B is a cross-sectional view sequentially illustrating manufacturing steps of the array of painless needles of the fourth embodiment.
  • FIG. 12C is a cross-sectional view sequentially illustrating manufacturing steps of the arrayed painless needle of the fourth embodiment.
  • FIG. 1A to 1C are views showing a first embodiment of the present invention, in which FIG. 1A is a plan view, FIG. 1B is a cross-sectional view between A and B in FIG. 1A, and FIG. 1C is an enlarged perspective view of a convex portion in FIG. FIG.
  • an array of painless needles is illustrated as an example of the drug delivery device of the present invention.
  • reference numeral 1 denotes an array of painless needles
  • 2 denotes a base material
  • 3 denotes a convex portion
  • 3A denotes an inclined surface.
  • the array of painless needles 1 has a base 2 and a first angle ⁇ 1 with respect to the surface thereof and a second angle ⁇ 2 different from the first angle ⁇ 1. It has a configuration having a protruding portion 3 having a substantially conical shape standing upright.
  • the first angle ⁇ 1 is substantially perpendicular to the surface of the base 2, and a second angle ⁇ 2 different from ⁇ 1 is appropriately set on a part of the convex portion 3 so that the inclined surface 3A By forming this, the tip of the convex part 3 is sharply formed.
  • each part in Fig. 2 can be set within the following range, for example.
  • (a) is a cross-sectional view of the main part of the array of painless needles 1
  • (b) is a perspective view of the convex part 3.
  • the size of the device is limited in particular, and the size can be changed in any way by the initial design and the manufacturing process thereof.
  • the first angle ⁇ 1 is about 90 degrees and the second angle ⁇ 2 is about 70 degrees.
  • these angles ⁇ 1 and ⁇ 2 have a relationship of first angle ⁇ 1> second angle ⁇ 2.
  • the first angle ⁇ 1 is 70 degrees to More preferably, it is in the range of 90 degrees
  • the second angle ⁇ 2 is 50 degrees to 80 degrees.
  • FIG. 3 is a cross-sectional view showing an example of a method for manufacturing the array of painless needles 1 in the order of steps.
  • the array of painless needles 1 includes a step B of forming a substantially columnar convex portion 8 erected at a first angle ⁇ 1 with respect to the surface of the Si base material 4; On the convex part 8, the first Forming a tilted surface 3 mm having a second angle ⁇ 2 different from the angle ⁇ 1 and covering the convex portion 3 having a sharp tip as shown in FIG. ing.
  • step (b) a Si substrate is prepared, (b) a Cr layer is formed on the surface, and (c) a photoresist is formed on the Cr layer by a photolithography technique to form a convex pattern. (D) The Cr layer is wet-etched using this photoresist as a mask to form a Cr pattern, and (e) a substantially columnar protrusion is formed using the Cr pattern as a mask.
  • This Manufacturing Example 1 is merely an example, and the present invention It is not intended to limit this.
  • the base material indicates a material for forming the convex portion and the base portion, and the definition is different from the base portion that is one constituent portion of the drug delivery device.
  • FIG. 3 (a) shows a 1000 m thick single crystal silicon (Si) wafer (hereinafter referred to as Si substrate 4) used as a substrate in Production Example 1 and mirror-polished on one side.
  • Si substrate 4 a 1000 m thick single crystal silicon (Si) wafer
  • the mirror-polished surface is referred to as the surface.
  • FIG. 3 (b) shows the formation of a Cr layer 5 serving as an etching mask on the surface of the Si substrate 4.
  • a Cr layer 5 of about 1 ⁇ m is formed on the surface of the Si substrate 4 by sputtering.
  • Fig. 3 (c) shows the formation of a photoresist pattern on the convex portion.
  • a photoresist pattern on the convex portion By one photolithography technique, a negative pattern of the convex portion on the surface of the Si substrate 4, that is, a photoresist on the convex portion. 6 is left and a pattern is formed by removing the non-convex photoresist.
  • the diameter of the photoresist 6 was set to 50 ⁇ m.
  • FIG. 3 (d) shows the formation of a Cr pattern, and the Cr layer 5 disposed under the photoresist 6 is etched using the photoresist 6 formed in the step (c) as a mask. Cr pattern 7 is formed. Etching of Cr was performed by wet etching using an aqueous solution mainly composed of ceric nitrate and perchloric acid.
  • Fig. 3 (e) shows the formation of the convex portion, and the substantially patterned columnar convex portion 8 is formed on the surface of the Si base 4 using the Cr pattern 7 formed in the step (d) as a mask. To do.
  • the convex portion 8 is formed by a dry etching process. Si substrate 4 with Cr pattern 7 formed on dry etching equipment Installed in the chamber, evacuated, then mixed SF and O as etching gas
  • Etching was performed using 6 2 gas.
  • the etching time was set to 25 minutes.
  • a convex part 8 with an etching depth (convex part height) of about 150 m could be formed.
  • the Cr layer as a mask had a thickness of 0.7 / zm or more.
  • the etching rate ratio (selection ratio) between Si and Cr is 500: 1 or more.
  • the shape of the convex portion 8 can be changed to a substantially cylindrical force to a substantially conical shape depending on the etching conditions at this time (for example, the process pressure, the flow rate of the etching gas, and the amount of electric power applied to the high frequency).
  • the convex portion 8 was formed in a substantially cylindrical shape having a diameter of 50 m.
  • Cr pattern 7 remaining on the Si surface was removed by wet etching using an aqueous solution mainly composed of ceric nitrate and perchloric acid.
  • FIG. 3 (f) shows the completion of the tool (arrayed painless needle 1) from the convex processing, and this (f) convex processing step is performed by ionizing Si substrate 4 with convex 8 formed.
  • the etching was performed by placing the film at an arbitrary angle with respect to the gas flow and performing dry etching.
  • FIG. 4 is a configuration diagram showing an outline of the dry etching apparatus.
  • reference numeral 9 is a chamber of the dry etching apparatus, 10 is a high-frequency power source, and 11 is a jig for tilting at an arbitrary angle.
  • This chamber 9 is connected to an evacuation system, and the inside can be evacuated.
  • the chamber 9 is provided with an Ar gas supply pipe through which argon (Ar) gas, which is an ion gas source, flows between the electrodes.
  • Ar argon
  • the Si base material 4 on which the convex portions 8 are formed is disposed at an arbitrary angle with respect to the electrodes in the chamber 19 of the dry etching apparatus.
  • the jig 11 for tilting the Si substrate 4 at an arbitrary angle may be any one as long as it is made of a conductive material such as aluminum (A1).
  • a Si base material 4 having a substantially cylindrical convex portion 8 formed thereon was placed on the jig 11, the chamber 9 was evacuated, and etching was performed using Ar gas as an etching gas.
  • the array of painless needles 1 of the present embodiment has a substantially conical shape erected with a base 2 and a first angle ⁇ 1 and a smaller second angle ⁇ 2 relative to the surface thereof. Therefore, by appropriately setting the first angle ⁇ and the second angle ⁇ 2, the tip of the convex portion 3 can be sharply formed, and the puncture property to the skin is improved. be able to.
  • FIGS. 5A to 5C are views showing a second embodiment of the present invention
  • FIG. 5A is a plan view
  • FIG. 5B is a cross-sectional view between A and B in FIG. 5A
  • FIG. 5C is a convex portion of FIG. FIG.
  • an array of painless needles is illustrated as an example of the drug delivery device of the present invention.
  • reference numeral 12 denotes an array of painless needles
  • 13 denotes a base
  • 14 denotes a convex portion
  • 14A denotes an inclined surface.
  • the array of painless needles 12 includes a base portion 13 and a group of substantially columnar, substantially frustum, and substantially conical shapes that are erected with a first angle ⁇ 1 with respect to the surface thereof. And a convex portion 14 having a selected shape, and an inclined surface 14A having a second angle ⁇ 2 different from the first angle ⁇ 1 is formed on the convex portion.
  • each part in FIG. 6 can be set within the following range, for example.
  • (a) is a cross-sectional view of the main part of the array of painless needles 12, and (b) is a perspective view of the convex part 14.
  • Base thickness f 200-1000 ⁇ m.
  • the size of the device is limited in particular, and the size can be changed in any way by the initial design and the manufacturing process thereof.
  • the first angle ⁇ 1 is about 90 degrees and the second angle ⁇ 2 is about 70 degrees.
  • these angles ⁇ 1 and ⁇ 2 are defined as the first angle ⁇ 1> the first
  • the first angle ⁇ 1 is preferably in the range of 70 degrees to 90 degrees
  • the second angle ⁇ 2 is in the range of 50 degrees to 80 degrees. Is more preferable.
  • FIG. 7 is a cross-sectional view showing an example of a method for manufacturing the array of painless needles 12 in the order of steps.
  • FIG. 7 (a) shows the process of forming a substantially cylindrical convex portion 8 on the surface of the Si substrate 4, and the convex portion 8 is formed in the same manner as in the steps of FIGS. 3 (a) to (e). The details can be omitted.
  • 3A to 3E which are the same as in the case of Manufacturing Example 1, the substantially cylindrical convex portion 8 erected with the first angle ⁇ 1 with respect to the surface of the Si base 4 is formed. It is formed.
  • FIG. 7 (b) shows the completion of the convex part processing force instrument (array-shaped painless needle 12), and this process is performed by a focused ion beam (FIB) etching apparatus schematically shown in FIG. To do.
  • FIB focused ion beam
  • an XYZ (three-dimensional) precision stage 16 is provided in a chamber 15 that can be evacuated, and the Si substrate 4 is tilted at an arbitrary angle on the XYZ precision stage 16.
  • a jig 17 for placement is provided.
  • an ion gun shutter 18 is provided at a Ga ion introduction part connected to the chamber 19 so that the introduction part can be opened and closed. As shown in FIG.
  • a Si substrate 4 having a substantially cylindrical convex portion 8 is disposed in a chamber 115 of a FIB etching apparatus provided with an ion gun and an XYZ precision stage 16.
  • the Si substrate 4 is tilted at an arbitrary angle with respect to the ion gun using the jig 11.
  • This jig 11 can be made of any material as long as it is made of a conductive material such as A1! /.
  • the ion ion microscope (Scanning Ion Microscope: SIM) and XYZ precision stage 16 provided in the device are moved so that the part (projection tip) where you want to selectively irradiate ions comes to a predetermined position. Irradiate gallium (Ga) ions from a gun.
  • Ga gallium
  • the array of painless needles 12 according to the second embodiment has a second column that is smaller than the first angle ⁇ 1 and has a substantially columnar convex portion 14 erected on the base at a first angle ⁇ 1. Since the inclined surface 14A with an angle ⁇ 2 is formed, it is possible to form a needle-like part with a thick bottom bottom part that does not impair the ability to puncture the skin, thus improving the mechanical strength of the instrument. Can be made.
  • FIGS. 9A to 9C are views showing a third embodiment of the present invention
  • FIG. 9A is a plan view
  • FIG. 9B is a cross-sectional view between A and B in FIG. 9A
  • FIG. 9C is a convex portion of FIG. FIG.
  • an array of painless needles is illustrated as an example of the drug delivery device of the present invention.
  • reference numeral 19 denotes an array of painless needles
  • 20 denotes a base
  • 21 denotes a convex portion
  • 21A denotes an inclined surface
  • 22 denotes a through hole.
  • the array of painless needles 19 stands with a base 20 and a first angle ⁇ 1 and a second angle ⁇ 2 different from the first angle ⁇ 1 with respect to the surface thereof.
  • the projection has a substantially cone-shaped projection 21 and a through-hole path 22 penetrating from the back surface of the base 20 to the tip of the projection 21.
  • This through-hole path 22 is used for the purpose of supplying a medicine from the back surface of the base 20 and transporting the medicine into the living body or taking out body fluid such as blood aspirated and extracted from the living body from the back surface of the base 20. be able to.
  • each part in FIG. 10 can be set within the following range, for example.
  • (a) is a cross-sectional view of the main part of the array of painless needles 19, and (b) is a perspective view of the convex part 21.
  • Base thickness k 200-1000 ⁇ m.
  • the size of the device is limited in particular, and the size can be changed in any way by the initial design and the manufacturing process thereof.
  • the first angle ⁇ 1 is about 90 degrees and the second angle ⁇ 2 is about 70 degrees.
  • these angles ⁇ 1 and ⁇ 2 have the relationship of first angle ⁇ 1> second angle ⁇ 2.
  • the first angle ⁇ 1 is 70 degrees to More preferably, it is in the range of 90 degrees
  • the second angle ⁇ 2 is 50 degrees to 80 degrees.
  • the opening area of the through-hole path 22 is preferably 2 ⁇ 10_3 mm 2 or more. If the opening area of the through-hole path 22 is 2 ⁇ 10_3 mm 2 or more, it is possible to efficiently administer a pharmaceutical product or perform blood suction extraction through the through-hole path 22.
  • FIG. 11 is a cross-sectional view showing an example of a method for manufacturing the array of painless needles 19 in the order of steps.
  • An example of manufacturing the arrayed painless needle 19 of the third embodiment according to FIG. 11 will be described in detail in the following Manufacturing Example 3.
  • This Manufacturing Example 3 is merely an example and is intended to limit the present invention. Absent. Note that the description of the same parts as those in Production Example 1 is omitted.
  • the method of manufacturing the arrayed painless needles 19 having the through-hole paths 22 is selected from the group of the step A for forming the opening portions 24 to be the through-hole paths 22, the substantially columnar shape, the substantially frustum shape, and the substantially conical shape. Forming a convex portion 25 and then forming the opening 24 as a through-hole path 22 and a step C forming an inclined surface 21A having a second angle on one surface of the convex portion 25. .
  • FIG. 11 (a) is a Si wafer having a thickness of 500 m (hereinafter referred to as Si base material 23) having both surfaces mirror-polished for use as a base material in Production Example 3.
  • Si base material 23 having both surfaces mirror-polished for use as a base material in Production Example 3.
  • both sides of the Si base material 23 are distinguished as a surface A and a surface B.
  • FIG. 11 (b) shows the formation of the opening 24 that becomes the through-hole path 22, and this formation of the opening 24 is performed using the photolithography technique and the dry etching process described in Production Example 1.
  • the opening 24 to be the through-hole path 22 is formed on the surface B of the Si base material 23 (see Step B in FIG. 3).
  • the etching technique for forming this opening 24 is the Bocsh process.
  • Alternately known etching gas (e.g. SF) and deposition gas (e.g. CF) Therefore, a process in which plasma is generated and an etching process and a deposition process are repeated is preferable.
  • the Cr mask described in Process B of Production Example 1 is not necessary, and the opening 24 can be formed using the resist as a mask.
  • openings 24 having an opening diameter of 50 ⁇ m, a depth of 470 ⁇ m, and a pitch of 500 ⁇ m were formed on the Si surface B.
  • FIG. 11 (c) shows the formation of the convex portion, and after passing through the same process as Process B of Production Example 1 described above, Table A of Si base material 23 [this diameter is 80 ⁇ m, Protrusions with a height of 150 ⁇ m and a pitch of 500 ⁇ m were formed. At this time, the ⁇ and ⁇ double-sided patterns of the Si base material 23 were aligned at the same time of photolithography, and the center of the opening 24 and the center of the convex part 25 were aligned.
  • FIG. 11 (d) shows the formation of the through-hole path 22.
  • the A surface of the Si base material 23 is etched again by a dry etching process, thereby opening the opening.
  • the portion 24 becomes a through-hole path 22 penetrating from the back surface of the base material to the tip of the convex portion.
  • FIG. 11 (e) shows the completion of the tool (array-shaped painless needle 19) from the convex processing, and the back surface of the base 20 is obtained by performing the same process as in Step C of Production Example 1 described above.
  • An array-shaped hollow painless needle 19 having a through-hole path 22 penetrating to the tip of the convex portion 21 is obtained.
  • the array of hollow painless needles 19 can also be obtained by using the step C ′ described in Production Example 2 described above.
  • the tip of the convex portion 21 can be sharpened even if the diameter of the through-hole path 22 is increased (that is, the opening area is increased). Therefore, the fluidity of the pharmaceutical product is high and the through-hole path can be formed while maintaining the puncture property to the skin.
  • the opening area of the through-hole passage 22 that can sufficiently secure the fluidity of the drug is usually about 2 X 10 _3 mm 2 although it depends on the viscosity of the drug product. For roads, a diameter of about 50 ⁇ m is sufficient.
  • the diameter of the convex portion 21 is set to be different from the diameter of the through-hole path 22 in the present invention. Since it can be increased, the tolerance of positional accuracy is increased and the yield is improved.
  • FIGS. 12A to 12C are cross-sectional views showing an example of a method for producing an array of painless needles made of a thermoplastic polymer material according to the fourth embodiment of the present invention in the order of steps.
  • a mold having pores for forming convex portions and a thermoplastic polymer base material that becomes the array of painless needles are arranged to face each other ( Fig. 12A) Heats at least one of the mold and the thermoplastic polymer substrate, holds the thermoplastic polymer substrate under pressure (Fig. 12B), cools after molding, then cools the thermoplastic polymer substrate This is done by the process of releasing the material ( Figure 12C).
  • a mold having pores for forming convex portions used for molding is produced by the following method.
  • the pharmaceutical product transportation device exemplified in Production Example 1 is a master type, and then the surface of the master type is made conductive by sputtering a metal such as Ni, and then the shape of the master type is formed by Ni electroplating. Transcript.
  • FIG. 12A shows a Ni electroplating mold 30 having pores for forming convex portions used as molds in Production Example 4 and a plate-shaped polylactic acid having a thickness of 1000 m (hereinafter referred to as polylactic acid substrate 31). is there. Note that the array-shaped painless needle 1 exemplified in Production Example 1 was used as the master mold used for the manufacture of the Ni electric mold 30.
  • FIG. 12B shows a process of transferring the shape of the Ni electroplating mold 30 to the polylactic acid substrate 31.
  • the polylactic acid substrate 31 is pressed from above the Ni electromolding mold 30 with a pressure of about lOMPa. By holding for 10 minutes in the pressed state, the shape of the Ni electroplating mold 30 is transferred to the polylactic acid substrate 31 almost accurately.
  • FIG. 12C shows a process of releasing the polylactic acid base material. After cooling the Ni electric mold 30 and the polylactic acid substrate to 50 ° C, the polylactic acid substrate is released. [0058] Through the above steps, an array of painless needles 32 made of a polylactic acid material can be formed. Although not described in detail, this array-shaped painless needle is substantially the same shape as the shape of the array-shaped painless needle 1, which is a master type. And base 3 3.
  • the substrate used in this production example may be basically any thermoplastic polymer, but polylactic acid is non-toxic to living organisms and is bioabsorbable. For example, even if the convex portion 34 of the array of painless needles 32 is broken and remains in the body, it is preferable because it is decomposed in the body.
  • the shape of the convex portion is not limited to the examples of the above-described embodiments, and any shape may be used as long as the shape and size can be punctured without pain on the skin or the like.
  • Other examples of the shape of the convex portion include a substantially cylindrical shape, a substantially truncated cone shape, a substantially prismatic shape (triangular pyramid, quadrangular pyramid, etc.), a substantially truncated pyramid shape, and a substantially truncated pyramid shape. These can be changed in any way depending on the convex pattern of temporary photolithography and dry etching conditions when forming the convex.
  • the through hole formed in the array of hollow painless needles is not limited to a circular shape, and may have a square shape (triangle, square, etc.). This can also be changed in any manner by the opening pattern of temporary photolithography.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Manufacturing & Machinery (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

L'invention concerne un instrument d'administration de médicament grâce auquel l'administration de médicament ou l'extraction de sang par aspiration peut être réalisée de manière efficace. Ledit instrument d'administration de médicament est constitué d'une base et de convexités prévues au niveau d'un premier angle par rapport à la surface de la base et d'un second angle différent du premier dont la forme est choisie dans le groupe constitué de formes sensiblement colonnaire, conique et en broche. L'invention concerne en outre un procédé permettant de produire un instrument d'administration de médicament qui consiste à former des convexités prévues au niveau d'un premier angle par rapport à la surface de la base dont la forme est choisie dans le groupe de formes généralement colonnaire, conique et en broche, et à former un plan incliné dans chaque convexité dont le second angle est différent du premier tel que décrit ci-dessus.
PCT/JP2006/300398 2005-01-14 2006-01-13 Instrument d'administration de medicament et son procede de fabrication WO2006075716A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006552996A JP5053645B2 (ja) 2005-01-14 2006-01-13 医薬物運搬用器具とその製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005-007327 2005-01-14
JP2005007327 2005-01-14

Publications (1)

Publication Number Publication Date
WO2006075716A1 true WO2006075716A1 (fr) 2006-07-20

Family

ID=36677739

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/300398 WO2006075716A1 (fr) 2005-01-14 2006-01-13 Instrument d'administration de medicament et son procede de fabrication

Country Status (2)

Country Link
JP (1) JP5053645B2 (fr)
WO (1) WO2006075716A1 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008035874A (ja) * 2006-08-01 2008-02-21 Toppan Printing Co Ltd 針状体の製造方法
JP2008079915A (ja) * 2006-09-28 2008-04-10 Toppan Printing Co Ltd 針状体およびその製造方法
JP2008212458A (ja) * 2007-03-06 2008-09-18 Toppan Printing Co Ltd 針状体および針状体製造方法
JP2008212588A (ja) * 2007-03-08 2008-09-18 Toppan Printing Co Ltd 針状体、針状体製造方法および薬物輸送デバイス
JP2009072271A (ja) * 2007-09-19 2009-04-09 Toppan Printing Co Ltd 針状体および針状体の製造方法
JP2009142465A (ja) * 2007-12-14 2009-07-02 Fujikura Ltd 医薬物運搬用器具とその製造方法及び金型とその製造方法
JP2009225987A (ja) * 2008-03-21 2009-10-08 Toppan Printing Co Ltd 針状体
JP2011143098A (ja) * 2010-01-15 2011-07-28 Toppan Printing Co Ltd マイクロニードル製造方法およびマイクロニードル
JP2013090837A (ja) * 2011-10-26 2013-05-16 Toppan Printing Co Ltd 針状体の製造方法および針状体
US8696638B2 (en) 2009-07-23 2014-04-15 Hisamitsu Pharmaceutical Co., Inc. Microneedle array
US8911422B2 (en) 2010-02-24 2014-12-16 Hisamitsu Pharmaceutical Co., Inc. Micro-needle device
US9028463B2 (en) 2008-06-30 2015-05-12 Hisamitsu Pharmaceutical Co., Inc. Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device
JP2020131021A (ja) * 2019-02-12 2020-08-31 近畿精工株式会社 マイクロニードル

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190005478A (ko) * 2017-07-07 2019-01-16 경상대학교산학협력단 마이크로니들 디바이스

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002517300A (ja) * 1998-06-10 2002-06-18 ジョージア テック リサーチ コーポレイション 微小針デバイスおよび製造方法ならびにそれらの使用
WO2004035105A2 (fr) * 2002-10-13 2004-04-29 Nano Pass Technologies Ltd. Microaiguilles en polymere
JP2004148519A (ja) * 2002-10-28 2004-05-27 Kuraray Co Ltd 樹脂成形品の製造方法、型用金属構造体の製造方法及び樹脂成形品
JP2004524172A (ja) * 2001-02-05 2004-08-12 ベクトン・ディキンソン・アンド・カンパニー マイクロ突起物アレイおよびマイクロ突起物の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749792B2 (en) * 2001-07-09 2004-06-15 Lifescan, Inc. Micro-needles and methods of manufacture and use thereof
US6808518B2 (en) * 2001-09-28 2004-10-26 Ethicon, Inc. Methods and devices for treating diseased blood vessels
US7588552B2 (en) * 2002-03-04 2009-09-15 Nano Pass Technologies Ltd. Devices and methods for transporting fluid across a biological barrier
KR100563330B1 (ko) * 2003-01-16 2006-03-22 포스트마이크로 주식회사 Ｌｉｇａ공정을 이용한 폴리머 재질의 미세 바늘 어레이제조방법

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002517300A (ja) * 1998-06-10 2002-06-18 ジョージア テック リサーチ コーポレイション 微小針デバイスおよび製造方法ならびにそれらの使用
JP2004524172A (ja) * 2001-02-05 2004-08-12 ベクトン・ディキンソン・アンド・カンパニー マイクロ突起物アレイおよびマイクロ突起物の製造方法
WO2004035105A2 (fr) * 2002-10-13 2004-04-29 Nano Pass Technologies Ltd. Microaiguilles en polymere
JP2004148519A (ja) * 2002-10-28 2004-05-27 Kuraray Co Ltd 樹脂成形品の製造方法、型用金属構造体の製造方法及び樹脂成形品

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008035874A (ja) * 2006-08-01 2008-02-21 Toppan Printing Co Ltd 針状体の製造方法
JP2008079915A (ja) * 2006-09-28 2008-04-10 Toppan Printing Co Ltd 針状体およびその製造方法
JP2008212458A (ja) * 2007-03-06 2008-09-18 Toppan Printing Co Ltd 針状体および針状体製造方法
JP2008212588A (ja) * 2007-03-08 2008-09-18 Toppan Printing Co Ltd 針状体、針状体製造方法および薬物輸送デバイス
JP2009072271A (ja) * 2007-09-19 2009-04-09 Toppan Printing Co Ltd 針状体および針状体の製造方法
JP2009142465A (ja) * 2007-12-14 2009-07-02 Fujikura Ltd 医薬物運搬用器具とその製造方法及び金型とその製造方法
JP2009225987A (ja) * 2008-03-21 2009-10-08 Toppan Printing Co Ltd 針状体
US9028463B2 (en) 2008-06-30 2015-05-12 Hisamitsu Pharmaceutical Co., Inc. Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device
US8696638B2 (en) 2009-07-23 2014-04-15 Hisamitsu Pharmaceutical Co., Inc. Microneedle array
JP2011143098A (ja) * 2010-01-15 2011-07-28 Toppan Printing Co Ltd マイクロニードル製造方法およびマイクロニードル
US8911422B2 (en) 2010-02-24 2014-12-16 Hisamitsu Pharmaceutical Co., Inc. Micro-needle device
JP2013090837A (ja) * 2011-10-26 2013-05-16 Toppan Printing Co Ltd 針状体の製造方法および針状体
JP2020131021A (ja) * 2019-02-12 2020-08-31 近畿精工株式会社 マイクロニードル

Also Published As

Publication number Publication date
JPWO2006075716A1 (ja) 2008-06-12
JP5053645B2 (ja) 2012-10-17

Similar Documents

Publication Publication Date Title
WO2006075716A1 (fr) Instrument d'administration de medicament et son procede de fabrication
WO2006075689A1 (fr) Instrument d'administration de medicament et procede de production associe
US10105524B2 (en) Article with hollow microneedles and method of making
JP5020080B2 (ja) 医薬物運搬用器具の製造方法
JP4908893B2 (ja) 医薬物運搬用器具とその製造方法及び医薬物運搬用器具製造用金型の製造方法
US9283365B2 (en) Patch production
JP2006341089A (ja) 医薬物運搬用器具およびその製造方法
US9545507B2 (en) Injection molded microneedle array and method for forming the microneedle array
WO2008004597A1 (fr) Procédé de fabrication d'une micro-aiguille
JP2011072695A (ja) マイクロニードルアレイの製造方法とマイクロニードルアレイ構造体
JP5285943B2 (ja) 針状体アレイおよび針状体アレイ製造方法
JP4888011B2 (ja) 針状体およびその製造方法
CN114748779A (zh) 一种微针及其制造工艺
JP2010068840A (ja) 針状体および針状体製造方法
KR100943157B1 (ko) 미세바늘 어레이 제조용 금형과 이 금형의 제조방법 및, 이금형을 이용한 미세바늘 어레이
JP2018038508A (ja) 針状アレイシートの製造方法
JP2008046507A (ja) 原版及びマイクロニードルのパッチの製造方法、並びにマイクロニードルのパッチ
JP5412045B2 (ja) 針状体アレイおよびそのアレイ製造方法
JP2013252580A (ja) マイクロニードル構造体の製造方法
JP2013106831A (ja) 針状体の製造方法および針状体の転写版
JP5173332B2 (ja) マイクロニードルおよびマイクロニードル製造方法
JP2011078654A (ja) マイクロニードルアレイとマイクロニードルアレイの製造方法
JP5568234B2 (ja) 針状体および針状体製造方法
JP5223278B2 (ja) マイクロニードル製造方法
JP2009142465A (ja) 医薬物運搬用器具とその製造方法及び金型とその製造方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006552996

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06711683

Country of ref document: EP

Kind code of ref document: A1

WWW Wipo information: withdrawn in national office

Ref document number: 6711683

Country of ref document: EP